BioSpace News Archive

The Placing is conditional on admission of the new Polarean shares to trading on AIM which is expected to occur on or around 28 December 2018.

Cribs for Kids partners with the Aaron Matthew SIDS Research Guild to fund data driven research into Sudden Infant Death Syndrome

In Stand4Lyme Foundation’s new video, experts address the serious global consequences of Lyme and tick-borne diseases

Ensuring the safety of our nation’s drug supply is a cornerstone of our consumer protection mission. Overseeing the quality and safety of pharmaceutical manufacturing is key to these efforts.

The latest on association health plans, pre-existing conditions and fraud risks

PrinterPrezz Inc., a trailblazer in combining metal 3D printing, nanotechnologies and surgical expertise to design and manufacture next generation medical devices, today announced the opening of its first Innovation Center in the Silicon Valley.

- Today, Walmart and Express Scripts (NASDAQ: ESRX) announced an extension to the companies’ existing network agreement to provide access to Walmart’s prescription services for Express Scripts clients’ covered members.

Enzyvant, a biopharmaceutical company focused on developing therapies for people with rare diseases, today announced the appointment of George O. Elston as Chief Financial Officer and Head of Corporate Development.

Indivior PLC (LON: INDV) (“Indivior” or the “Company”) today announced that the U.S. Court of Appeals for the Federal Circuit (CAFC) has denied Dr. Reddy’s Laboratories (DRL’s) motion to immediately issue the mandate following the CAFC’s ruling vacating the preliminary injunction (PI).

AI diagnostics company IDx spent the first 8 years of its existence operating in stealth mode. But on April 11, 2018, that instantly changed when the company hit the national spotlight after receiving FDA clearance for IDx-DR, an autonomous AI system that detects diabetic retinopathy, the leading cause of blindness in the U.S.